Related Experiment Video
Updated: Mar 28, 2026
06:08
A Novel Method: Super-selective Adrenal Venous Sampling
Published on: September 15, 2017
24.5K
Progress in Primary Aldosteronism: Translation on the Move.
1Medizinische Klinik und Poliklinik IV, Klinikum der Universität München, Munich, Germany.
Hormone and Metabolic Research = Hormon- Und Stoffwechselforschung = Hormones Et Metabolisme
|December 16, 2015
Summary
Hypertension, a key cardiovascular risk, is often driven by the renin-angiotensin-aldosterone system (RAAS). Early detection of primary aldosteronism (PA) is crucial for better patient outcomes and survival.
Area of Science:
- Cardiovascular Medicine
- Endocrinology
- Hypertension Research
Background:
- Hypertension affects 10-40% of the population, increasing cardiovascular risk.
- The renin-angiotensin-aldosterone system (RAAS) critically regulates blood pressure and vascular function.
- Chronic RAAS activation, especially with high sodium intake, promotes inflammation, thrombosis, and atherosclerosis, leading to end-organ damage.
Discussion:
- Elevated renin and aldosterone levels are established predictors of adverse outcomes in various cardiovascular conditions, including heart failure and myocardial infarction.
- Primary aldosteronism (PA), the most common secondary hypertension, affects 4-12% of hypertensive individuals and up to 20% of treatment-resistant cases.
- Aldosterone excess causes severe cardiovascular damage independent of blood pressure levels, highlighting the importance of PA diagnosis.
Key Insights:
- RAAS activation is central to hypertension pathophysiology and its associated complications.
- Primary aldosteronism is a prevalent and underdiagnosed cause of secondary hypertension.
- Identifying and treating PA significantly improves cardiovascular outcomes and patient survival.
Outlook:
- Further research into RAAS modulation and PA screening is warranted.
- Developing more effective diagnostic tools for PA can improve early detection rates.
- Integrating PA management into standard hypertension care protocols is essential for reducing cardiovascular morbidity and mortality.
More Related Videos
Related Concept Videos
01:33Hormonal Regulation
37.0K
The renin-aldosterone system is an endocrine system which guides the renal absorption of water and electrolytes, thus managing blood pressure and osmoregulation. Activation of the system begins in the kidneys with a small cluster of cells adjacent to the afferent and efferent blood vessels of the renal corpuscle. As the nephrons are filtering blood, juxtaglomerular cells monitor blood pressure. If they detect a decrease in pressure, they release the hormone renin into the bloodstream.
37.0K
01:27Adrenal Gland Disorders
3.9K
Adrenal gland disorders manifest when the production of adrenal hormones deviates from the norm, resulting in either excessive or insufficient concentrations.
Adrenal insufficiency, characterized by insufficient cortisol and aldosterone production, leads to conditions like Addison's disease. This disorder, affecting the adrenal cortex, exhibits symptoms such as skin bronzing, dehydration, low blood pressure, fatigue, and weight loss. Congenital adrenal hyperplasia, a genetic ailment causing...
Adrenal insufficiency, characterized by insufficient cortisol and aldosterone production, leads to conditions like Addison's disease. This disorder, affecting the adrenal cortex, exhibits symptoms such as skin bronzing, dehydration, low blood pressure, fatigue, and weight loss. Congenital adrenal hyperplasia, a genetic ailment causing...
3.9K
01:30Antihypertensive Drugs: Angiotensin II Receptor Blockers
3.0K
In the renin-angiotensin-aldosterone system, a hormone called angiotensin II plays a crucial role. It binds to the AT1 receptors in vascular smooth muscles coupled with Gq proteins. The activation of these receptors activates an enzyme called phospholipase C, which releases two molecules: inositol trisphosphate and diacylglycerol. These molecules cause a chain reaction that leads to the phosphorylation of myosin light chains and promotes interaction between actin and myosin, leading to smooth...
3.0K
01:17Antihypertensive Drugs: Action of β1 Blockers
2.2K
β1-receptors are primarily located in the heart and kidneys. In cardiac myocytes, these receptors interact with neurotransmitters released by the sympathetic nervous system during heightened activity or danger. As a result, β1-receptors get activated, initiating a series of biochemical processes. Excessive activation of beta receptors due to chronic stress can abnormally increase heart rate and contractility, resulting in high blood pressure or hypertension. To counteract this,...
2.2K
01:28Antihypertensive Drugs: Potassium-Sparing Diuretics
2.7K
Liddle syndrome is a genetically inherited form of hypertension characterized by the overactivity of epithelial sodium channels in the nephron, the functional unit of the kidney. This heightened activity leads to increased sodium reabsorption and excessive excretion of potassium. To counteract this, potassium-sparing diuretics such as amiloride are used. They function by blocking these sodium channels, thereby reducing the influx of sodium into the epithelial cells and minimizing the loss of...
2.7K
01:22Adrenergic Antagonists: Pharmacological Actions of ɑ-Receptor Blockers
1.8K
α-Adrenergic antagonists, known as α-blockers, exert their effects by inhibiting α-adrenoceptors, leading to specific physiological actions. α1-blockers and α2-blockers have distinct pharmacological actions and therapeutic applications.
α1-blockers: These drugs inhibit α1-adrenoceptors on smooth muscle cells, resulting in vasodilation. This vasodilation lowers blood pressure, making α1-blockers valuable in treating hypertension. Additionally,...
α1-blockers: These drugs inhibit α1-adrenoceptors on smooth muscle cells, resulting in vasodilation. This vasodilation lowers blood pressure, making α1-blockers valuable in treating hypertension. Additionally,...
1.8K